Clinical trial
Safety and Immunogenicity of Various Formulations of Live Attenuated Tetravalent…
NCT00350337 · U.S. Army Medical Research and Development Command, U.S. Fed · Completed
Key facts
| NCT number | NCT00350337 |
|---|---|
| Title | Safety and Immunogenicity of Various Formulations of Live Attenuated Tetravalent Dengue Vaccine in Healthy US Adults |
| Official title | Phase II, Randomized, Observer-Blind, Single Center, Controlled Study of Two Doses of Various Formulations of WRAIR Live Attenuated Tetravalent Dengue Vaccine Compared to Placebo Control Administered on 0-6-Month Schedule to Healthy Adults |
| Lead sponsor | U.S. Army Medical Research and Development Command, U.S. Fed |
| Collaborators | GlaxoSmithKline Industry Walter Reed Army Institute of Research (WRAIR) U.S. Fed |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Dengue |
| Intervention type | Biological, Other |
| Interventions | Pre-transfection F17, Post-transfection F17, Post-transfection F19, Placebo |
| Enrollment | 86 |
| Start date | Apr 5, 2006 |
| Primary completion | Jun 20, 2007 |
| Completion | Mar 13, 2008 |
| First posted | Jul 10, 2006 |
| Last update posted | Feb 12, 2021 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: